ArticleBlood2009

Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.

Francois Romagné et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.